Search for Clinical Trial Results

Sponsored By

Carcinoma, Intraductal, Noninfiltrating - 6 Studies Found

Status Study
Active, not recruiting Study Name: Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)
Condition: Carcinoma, Intraductal, Noninfiltrating
Date: 2016-08-10
Interventions: Drug: Pembrolizumab Other Names:
  • Keytruda
  • MK-3475
Completed Study Name: Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Condition:
  • Carcinoma, Intraductal, Noninfiltrating
  • DCIS
  • Drug: Chloroquine Standard Dose (500mg/week)

Recruiting Study Name: Women Informed to Screen Depending on Measures of Risk
Condition:
  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating
    • <
    Date: 2015-12-01
    Interventions:
    • Other: Complete a health questionnaire

Not yet recruiting Study Name: Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Condition: Breast Cancer
Date: 2008-11-07
Interventions:
  • Drug: vorinostat
  • Genetic: protein expressi
Completed Study Name: Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condition: Ductal Carcinoma in Situ
Date: 2011-06-09
Interventions: Drug: SOM 230 / Pasireotide SOM230/Pasireotide is a multi-receptor targeted somatostatin analogue. In th
Terminated Study Name: Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Date: 2006-02-09
Interventions:
  • Drug: Tamoxifen Tamoxifen may